Literature DB >> 2571961

Xerostomia. Part II: Relationship to nonoral symptoms, drugs, and diseases.

L M Sreebny1, A Valdini, A Yu.   

Abstract

Five hundred twenty-nine adult outpatients were studied to determine the relationship of xerostomia to other oral symptoms and salivary flow (reported in part I) and to nonoral symptoms, drugs, and select diseases (reported here in Part II). It was observed that dry throat, blurred vision, dry eyes, dry skin, and vaginal itching and fungal infections are prominently associated with oral dryness. These nonoral symptoms were positively correlated with the oral symptoms cited in part I of this study and were inversely related to the flow of resting, but not stimulated, whole saliva. Several classes of drugs were associated with dry mouth. In addition, diabetes mellitus and hypertension were significantly associated with it. Approximately half of the diabetic and hypertensive patients complained of dry mouth. Although a majority of them were taking medications, the association between xerostomia and these diseases cannot be completely attributed to drugs, since many of these patients did not take any xerogenic medicaments. The data show that xerostomia and several other oral symptoms are valid indicators of salivary gland hypofunction. They suggest, moreover, that select nonoral symptoms are an indicator of generalized xerosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571961     DOI: 10.1016/0030-4220(89)90140-0

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  26 in total

1.  Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis.

Authors:  T Uhlig; T K Kvien; J L Jensen; T Axéll
Journal:  Ann Rheum Dis       Date:  1999-07       Impact factor: 19.103

Review 2.  Therapeutic drug monitoring in saliva. An update.

Authors:  R K Drobitch; C K Svensson
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

3.  Measurement of whole unstimulated salivary flow in the diagnosis of Sjögren's syndrome.

Authors:  P M Speight; A Kaul; R D Melsom
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

4.  Evaluation of Xerostomia in Different Psychological Disorders: An Observational Study.

Authors:  Suresh Kandagal Veerabhadrappa; Pramod Redder Chandrappa; Snehal Patil; Seema Yadav Roodmal; Akshay Kumarswamy; Mounesh Kumar Chappi
Journal:  J Clin Diagn Res       Date:  2016-09-01

Review 5.  Xerostomia and hyposalivation: causes, consequences and treatment in the elderly.

Authors:  T O Närhi; J H Meurman; A Ainamo
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

6.  Impact of gender on insulin signaling pathway in lacrimal and salivary glands of rats.

Authors:  Eduardo M Rocha; A Emiko Hirata; Everardo M Carneiro; Mário J A Saad; Lício A Velloso
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

7.  Signs and symptoms in patients with salivary gland hypofunction.

Authors:  L P Longman; S M Higham; R Bucknall; S B Kaye; W M Edgar; E A Field
Journal:  Postgrad Med J       Date:  1997-02       Impact factor: 2.401

8.  Management of xerostomia in older patients : a randomised controlled trial evaluating the efficacy of a new oral lubricant solution.

Authors:  Stéphane Mouly; Michel Salom; Yves Tillet; Anne-Claude Coudert; Frantz Oberli; Philip M Preshaw; Stéphane Desjonquères; Jean-François Bergmann
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

9.  Effects of Chinese herbs on salivary fluid secretion by isolated and perfused rat submandibular glands.

Authors:  Masataka Murakami; Mu-Xin Wei; Wei Ding; Qian-De Zhang
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

10.  Pre-therapeutic dosimetry of normal organs and tissues of (177)Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer.

Authors:  Levent Kabasakal; Mohammad AbuQbeitah; Aslan Aygün; Nami Yeyin; Meltem Ocak; Emre Demirci; Turkay Toklu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-31       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.